Search | SocialyTime

Atharva Patil added blog Health
2026-03-20 09:32:38 -

Beyond Small Molecules: Gene Therapy and Protein Replacement in the Friedreich’s Ataxia Drug Market
The approval of small-molecule therapies that manage oxidative stress was a monumental victory for patients living with Friedreich’s Ataxia (FA). However, drugs that treat the symptoms and slow the progression do not cure the underlying genetic defect. As the biotechnology sector pushes the boundaries of molecular medicine, the Friedreich’s Ataxia Drug Market is actively pivoting...

0 Comments 0 Shares 53 Views 0 Reviews

Please log in to like, share and comment!
Idebenone Website added blog Other
2026-01-19 05:29:34 -

Breakthroughs in Friedreich’s Ataxia Treatment: From Hope to Reality
1. Introduction: Friedreich’s Ataxia Friedreich’s ataxia (FRDA) is a rare inherited neurodegenerative disorder that affects the nervous system and heart. It is caused by a GAA trinucleotide repeat expansion in the FXN gene on chromosome 9, leading to reduced production of frataxin, a mitochondrial protein vital for iron–sulfur (Fe–S) cluster formation. This deficiency...

0 Comments 0 Shares 575 Views 0 Reviews

Please log in to like, share and comment!
Shweta Kadam added blog Other
2026-01-27 04:47:43 -

Friedreich’s Ataxia Market Overview: Growth, Share, Value, Size, and Scope
Introduction Friedreich’s Ataxia is a rare, inherited neurodegenerative disorder that primarily affects the nervous system and heart, leading to progressive loss of coordination, muscle weakness, speech difficulties, and cardiomyopathy. Caused by mutations in the FXN gene, the disease typically manifests in childhood or adolescence and worsens over time, significantly impacting...

0 Comments 0 Shares 379 Views 0 Reviews

Please log in to like, share and comment!
Shweta Kadam added blog Other
2025-11-30 00:57:57 -

Friedreich’s Ataxia Market Size: Growth, Share, Value, Trends, and Analysis
"Global Demand Outlook for Executive Summary Friedreich’s Ataxia Market Size and Share The global Friedreich’s Ataxia market size was valued at USD 2.63 billion in 2024 and is expected to reach USD 3.59 billion by 2032, at a CAGR of 4.00% during the forecast period. For a constantly increasing business growth and maximum return on investment...

0 Comments 0 Shares 774 Views 0 Reviews

Please log in to like, share and comment!